VIDEO INTERVIEWS
Join Professor Martin Savage and expert colleagues for this series of interviews as they explore different perspectives and insights into how to successfully implement precision medicine into the management of paediatric endocrine disorders.
- June 24, 2022
A 4-year-old boy of Bangladeshi origin was referred to paediatric endocrine clinic by his community paediatrician due to concerns of precocious puberty.
- June 8, 2021
This is the 8th IMAGE conference, which focuses on differences in sexual development, and puberty disorders and reproductive problems in adolescents and young adults.
- December 16, 2021
In our latest podcast, Specialist nurse and educator Kate Davies asks clinical psychologist Julie Alderson about the optimal integration of psychology into a differences in sexual development clinical service.
Open Access Article Now Available
Digital technologies to improve the precision of paediatric growth disorder diagnosis and management
View the article published in the Growth Hormone & IGF Research journal that summarises the webinar discussion on the role of digital health in growth disorders.
- October 31, 2022
A weekly injectable PEGylated recombinant human growth hormone gives significantly better height outcomes than no treatment in children with idiopathic short stature, shows a phase 2 trial.
- October 4, 2022
Cardiometabolic risk in people born small for gestational age more than a decade after finishing therapy with recombinant human growth hormone is no higher than in those never given the treatment, a study shows.
- October 4, 2022
Analysis of real-world data indicates that the recombinant human growth hormone somatropin is well tolerated and effective for children with a range of growth hormone disorders and other conditions associated with short stature.
